CHM 0.00% 1.4¢ chimeric therapeutics limited

There could be a couple of catalyst for the sp in the near...

  1. 263 Posts.
    lightbulb Created with Sketch. 64
    There could be a couple of catalyst for the sp in the near term

    Positive cohort 3 readout
    cdh17 trial commencement
    NK combo trial update

    my worry is that any potential positive sp catalyst won’t move the sp in the current macro environment.

    I have seen some really impressive results elsewhere and the sp of those companies has gone down

    there will most likely be some unfavourable diluition with either a sophisticated cr or shares issued to L1 or a combo of these

    hopefully chm can keep it to a minimum and hold off on larger raises until sp can better reflect intrinsic value




 
watchlist Created with Sketch. Add CHM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.